News & Analysis as of

Political Appointments Regulatory Agenda

Manatt, Phelps & Phillips, LLP

Key Governor Kathy Hochul Appointments (Revised 11/4/21)

Since assuming office on August 24, Governor Kathy Hochul has continued assembling her team while continuing to focus on the state’s response to the ongoing COVID-19 pandemic. The Governor has announced a number of Executive...more

Manatt, Phelps & Phillips, LLP

Key Governor Kathy Hochul Appointments

Since assuming office on August 24, Governor Kathy Hochul has been assembling her team while continuing to focus on the state’s response to the ongoing COVID pandemic. The Governor has announced a number of executive chamber...more

Proskauer - Government Contractor Compliance...

Jenny Yang Will Be The Next OFCCP Director

As previously reported, the new Biden Administration is wasting no time in making changes impacting the government contractor community. This now includes changing leadership at the OFCCP. As was anticipated, and is now...more

Franczek P.C.

Boston Mayor and Friend to Labor Marty Walsh to Head USDOL

Franczek P.C. on

Media reports indicate that President-Elect Joe Biden will tap Boston Mayor Marty Walsh to serve as Secretary of Labor in his administration....more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Beltway Buzz - November 2020 #2

Biden Agency Review Teams Announced. President-elect Joe Biden has announced his “agency review teams” to begin evaluating agency operations in anticipation of the shift in executive power in January 2021. The labor review...more

Bracewell LLP

Post-Election Update 2018

Bracewell LLP on

2018 MIDTERMS: The Power of Women, Possibility, and Partisan Rancor - The 2018 midterm elections showcased the power of women, both as candidates and as a key voting demographic. The elections represented a new political...more

Goodwin

Scott Gottlieb’s Stance on Biosimilars

Goodwin on

On May 11, 2017, Scott Gottlieb was sworn in as the 23rd Commissioner of the U.S. Food & Drug Administration. Before his confirmation, Gottlieb was vocal about his disapproval of the FDA’s “well-established” attitude: an...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide